oxprenolol has been researched along with Coronary Disease in 46 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of two preparations of oxprenolol (80 mg twice a day; 160 mg slow-release once a day) on the diurnal non-steady-state exercise performance in patients with coronary heart disease (N = 11) has been studied after a treatment period of at least 7 days." | 9.05 | Effects of different preparations of oxprenolol on diurnal variations of non-steady-state exercise performance in patients with coronary heart disease evaluated by computer assisted ergospirometry. ( Reiterer, W, 1980) |
| "The effect of two preparations of oxprenolol (80 mg twice a day; 160 mg slow-release once a day) on the diurnal non-steady-state exercise performance in patients with coronary heart disease (N = 11) has been studied after a treatment period of at least 7 days." | 5.05 | Effects of different preparations of oxprenolol on diurnal variations of non-steady-state exercise performance in patients with coronary heart disease evaluated by computer assisted ergospirometry. ( Reiterer, W, 1980) |
| "Twenty patients with coronary heart disease participated in a double-blind, randomized, crossover study on three study mornings to evaluate the effect of oral oxprenolol 80 mg, oral propranolol 80 mg, and placebo on left ventricular contractility." | 5.04 | Effects of oxprenolol and propranolol on systolic time intervals. ( Aronow, WS; van Herick, R, 1978) |
| "Oxprenolol is a potent noncardioselective beta-adrenoceptor blocking drug with partial agonist activity of proved efficacy and high tolerability in patients at risk of various cardiovascular disease syndromes." | 2.36 | Oxprenolol in clinical practice. ( Taylor, SH, 1983) |
| "To determine the protective effect of oxprenolol-induced beta-blockade on the compromised myocardium (critical constriction of the left anterior descending coronary artery) against the adverse effect of high concentrations of halothane, halothane dose-response curves were obtained in six dogs in each of three phases: preconstriction (control), critical constriction, and critical constriction with the addition of 0." | 1.27 | Beta-blockade reverses regional dysfunction in ischemic myocardium. ( Cutfield, GR; Foëx, P; Francis, CM; Lehot, JJ; Leone, BJ, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (95.65) | 18.7374 |
| 1990's | 1 (2.17) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (2.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Sun, N | 1 |
| Jiang, X | 1 |
| Xi, Y | 1 |
| Reiterer, W | 2 |
| Taylor, SH | 5 |
| Silke, B | 4 |
| Lee, PS | 2 |
| Henderson, A | 1 |
| Sheridan, D | 1 |
| Ross, J | 1 |
| Lewis, M | 1 |
| Nayler, WG | 1 |
| Hilal, A | 1 |
| Frishman, WH | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Krämer, B | 1 |
| Kübler, W | 1 |
| Duman, VL | 1 |
| Rozhdestvenskaia, ED | 1 |
| Oranskiĭ, IE | 1 |
| Elson, JJ | 1 |
| Ten Eick, RE | 1 |
| Singer, DH | 1 |
| Ebbutt, A | 1 |
| Sutton, GC | 1 |
| Prout, BJ | 1 |
| Burley, DM | 1 |
| John, VA | 1 |
| Calvert, RT | 1 |
| Manning, AS | 3 |
| Keogh, JM | 3 |
| Coltart, DJ | 3 |
| Hearse, DJ | 3 |
| Machtey, I | 1 |
| Shattock, MJ | 1 |
| Marcomichelakis, J | 2 |
| Donaldson, R | 1 |
| Green, J | 1 |
| Joseph, S | 2 |
| Kelly, HB | 2 |
| Taggart, P | 3 |
| Somerville, W | 4 |
| Maksimova, LN | 1 |
| Sandomirskiĭ, BL | 1 |
| Reale, A | 1 |
| Nigri, A | 1 |
| Gioffrè, PA | 1 |
| Motolese, M | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Fox, KM | 1 |
| Chopra, MP | 1 |
| Portal, RW | 1 |
| Aber, CP | 1 |
| van Herick, R | 1 |
| Aronow, WS | 1 |
| Carruthers, M | 2 |
| Noble, D | 1 |
| O'Neill, G | 1 |
| Contino, A | 1 |
| Risica, G | 1 |
| Benzoni, A | 1 |
| Zagatti, G | 1 |
| Caturelli, G | 1 |
| Ermilov, LP | 2 |
| Safronnikov, LV | 1 |
| Kuleshova, EV | 1 |
| Muiesan, G | 1 |
| Valori, C | 1 |
| Rivier, JL | 1 |
| Monti, M | 1 |
| Mazzoni, S | 1 |
| Reymond, C | 1 |
| Jaggi, CP | 1 |
| Jaeger, M | 1 |
| Piatak, OA | 1 |
| Yanovskii, GV | 1 |
| Lizogub, VG | 1 |
| Harvengt, C | 1 |
| Desager, JP | 1 |
| Heller, F | 1 |
| Hulhoven, R | 1 |
| Leone, BJ | 1 |
| Lehot, JJ | 1 |
| Francis, CM | 1 |
| Cutfield, GR | 1 |
| Foëx, P | 2 |
| Stone, JG | 1 |
| Sear, JW | 1 |
| Johnson, LL | 1 |
| Khambatta, HJ | 1 |
| Triner, L | 1 |
| Adamska-Dyniewska, H | 2 |
| Liutoev, GI | 1 |
| Judge, TG | 1 |
| Bakst, A | 1 |
| Lewis, BS | 1 |
| Gotsman, MS | 1 |
| Fomina, AA | 1 |
| Spivak, AM | 1 |
| Mironova, KA | 1 |
| Reingardt, BK | 1 |
| Vaisrub, S | 1 |
| Lecerof, H | 1 |
| Malmborg, RO | 1 |
| Hoszowski, K | 1 |
| Prosińska-Kibler, M | 1 |
5 reviews available for oxprenolol and Coronary Disease
| Article | Year |
|---|---|
Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Atenolol; Coronary Disease; Human | 2017 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Death | 1984 |
Oxprenolol in clinical practice.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Heart Rate; Humans; Hyperte | 1983 |
Vasodilators..
Topics: Adrenergic alpha-Antagonists; Aminophylline; Angina Pectoris; Bradycardia; Bronchial Diseases; Cereb | 1974 |
12 trials available for oxprenolol and Coronary Disease
| Article | Year |
|---|---|
[Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
Topics: Adrenergic beta-Antagonists; Coronary Disease; Drug Therapy, Combination; Fendiline; Hemodynamics; H | 1980 |
Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Hear | 1982 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Prevention of heart disease with oxprenolol.
Topics: Clinical Trials as Topic; Coronary Disease; Female; Humans; Male; Oxprenolol | 1983 |
A long-term prevention study with oxprenolol in coronary heart disease.
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Male; Middle A | 1982 |
Effects of different preparations of oxprenolol on diurnal variations of non-steady-state exercise performance in patients with coronary heart disease evaluated by computer assisted ergospirometry.
Topics: Adult; Biological Availability; Circadian Rhythm; Coronary Disease; Heart Rate; Humans; Male; Middle | 1980 |
Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Coronary Disease; Exercise Test; Female; H | 1979 |
Effects of oxprenolol and propranolol on systolic time intervals.
Topics: Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Heart Rate; Humans; | 1978 |
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Tes | 1991 |
Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Clinical Trials as To | 1988 |
Electrocardiogram, plasma catecholamines and lipids, and their modification by oxyprenolol when speaking before an audience.
Topics: Administration, Oral; Adult; Catecholamines; Cholesterol; Clinical Trials as Topic; Coronary Disease | 1973 |
Editorial: Unaccustomed as I am to.
Topics: Autonomic Nervous System; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Epinephri | 1973 |
30 other studies available for oxprenolol and Coronary Disease
| Article | Year |
|---|---|
Factors relating to the beta blocker withdrawal syndrome.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Rate; Humans; Hyperthyroi | 1981 |
The pharmacological protection of the ischaemic heart: the use of calcium and beta-adrenoceptor antagonists.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Coronary Dis | 1980 |
Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Coronary Disease; Dose-Response | 1982 |
[Use of the beta adrenergic blockader test for evaluation of extracardiac regulation of heart function in patients with coronary pathology of various degrees of severity].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Coronary Disease; Heart; Humans; Male; Middle A | 1984 |
Autonomic nervous system and cellular injury from circumflex ligation in dogs.
Topics: Animals; Cardiac Pacing, Artificial; Coronary Disease; Coronary Vessels; Denervation; Dogs; Heart; H | 1981 |
Initiation and maintenance of beta-blockade with intravenous oxprenolol.
Topics: Adult; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; | 1983 |
The effect of beta blockade and partial agonist activity during myocardial ischemia.
Topics: Animals; Coronary Disease; Creatine Kinase; Enzyme Induction; Heart Arrest, Induced; Male; Oxprenolo | 1983 |
Polyarthritis following propranolol.
Topics: Angina Pectoris; Arthritis; Coronary Disease; Female; Humans; Male; Middle Aged; Oxprenolol; Propran | 1981 |
Beta-blockade and ischaemic injury: effects of partial agonist activity.
Topics: Animals; Coronary Disease; Creatine Kinase; Heart; In Vitro Techniques; Isoproterenol; Male; Myocard | 1980 |
Long-term beta-blockade: prolonged protective action on the ischaemic myocardium.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Glycogen; Hemodynamics; In | 1981 |
Exercise testing after beta-blockade: improved specificity and predictive value in detecting coronary heart disease.
Topics: Adolescent; Adult; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Echocardiography | 1980 |
[Effect of adrenergic beta receptor blockaders on bronchial patency in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Bronchi; Bronchial Spasm; Coronary Disease; Humans; Oxprenolol; Pindolo | 1978 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
Long-term beta blockade: possible protection from myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; Cor | 1975 |
Electrocardiographic changes resembling myocardial ischaemia in asymptomatic men with normal coronary arteriograms.
Topics: Adolescent; Adult; Aerospace Medicine; Cardiac Catheterization; Catecholamines; Coronary Angiography | 1979 |
[Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Drug Evaluation; Drug Synergism; Elec | 1979 |
[Oxprenol and platelet aggregation (author's transl)].
Topics: Adenosine Diphosphate; Aged; Coronary Disease; Epinephrine; Humans; Middle Aged; Oxprenolol; Platele | 1978 |
[Comparative effectiveness of inderal and trazikor in the treatment of chronic ischemic heart disease].
Topics: Coronary Disease; Female; Humans; Male; Oxprenolol; Propranolol | 1977 |
[Sympathetic nervous activity and ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Catecholamines; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; M | 1977 |
[The role of reduction of the heart rate in the favorable effect of the beta blockers on myocardial ischemia due to isoprenalin in patients with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Humans; Isoproterenol; Male; Middle Aged; Ox | 1977 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hyper | 1987 |
Beta-blockade reverses regional dysfunction in ischemic myocardium.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Coronary Disease; Disease Models, Animal | 1987 |
[Comparison of the effects of propranolol, practolol, oxyprenolol and L.B. 46 on myocardial contractility].
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Arteriosclerosis; Coronary Disease | 1973 |
[Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Coronary Disease; Exercise Test; Heart; H | 1973 |
[Effect of inderal and trasicor on the function of external respiration in chronic coronary insufficiency].
Topics: Acid-Base Equilibrium; Adrenergic beta-Antagonists; Adult; Aged; Chronic Disease; Coronary Disease; | 1973 |
Atrial pacing in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Coronary Disease; Heart Block; Heart Rate; Huma | 1972 |
[Use of trasycor in disorders of the cardiac rhythm and ischemic heart disease].
Topics: Administration, Oral; Arrhythmias, Cardiac; Coronary Disease; Humans; Oxprenolol | 1974 |
Hemodynamic effects of oxprenolol alone and combined with nitroglycerin in patients with ischemic heart disease.
Topics: Administration, Oral; Adult; Angina Pectoris; Blood Pressure; Carbon Dioxide; Cardiac Catheterizatio | 1972 |
[Effect of oxprenolol on the dynamics of left ventricular contraction in patients with coronary disease].
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Coronary Disease; Female; Heart; Heart Rate; Hear | 1972 |
Emotions, catecholamines and coronary heart disease.
Topics: Automobile Driving; Catecholamines; Coronary Disease; Electrocardiography; Emotions; Fatty Acids, No | 1973 |